CDKN2B-AS1 and leukemia: Heuston et al., referred to several reports on lncRNAs such as ANRIL, lncRNA-P21, MEG3, Dleu2, HOTAIRM1, EGO, and lncRNA-a7 in leukemia, highlighting the potential benefit of research on lncRNAs for the development of much needed diagnostic, prognostic, and therapeutic targets (Heuston et al., 2011).